BRIEF published on 05/19/2026 at 07:05, 1 month 5 days ago Innate Pharma at the Jefferies Global Healthcare Conference Immunotherapy Cancer Innate Pharma Therapeutic Antibodies Jefferies Conference
BRIEF published on 05/19/2026 at 07:05, 1 month 5 days ago Innate Pharma to Attend Jefferies Global Healthcare Conference Biotechnology Cancer Treatment Immunotherapy Innate Pharma Jefferies Conference
PRESS RELEASE published on 05/19/2026 at 07:00, 1 month 5 days ago Inside Information / Other news releases Innate Pharma to participate in Jefferies Global Healthcare Conference on June 2-4, 2026 in New York, United States. Developing immunotherapies for cancer patients Biotechnology Innate Pharma Jefferies Global Healthcare Conference Immunothérapies Cancer Patients
BRIEF published on 04/17/2026 at 21:05, 2 months 6 days ago Innate Pharma presents interim results from the MATISSE trial at the AACR congress Lung Cancer Innate Pharma AACR 2026 IPH5201 Phase 2 MATISSE
BRIEF published on 04/17/2026 at 21:05, 2 months 6 days ago Innate Pharma Reveals Promising Interim Results in MATISSE Phase 2 Study Clinical Trials Lung Cancer Innate Pharma MATISSE Phase 2 IPH5201
PRESS RELEASE published on 04/17/2026 at 21:00, 2 months 6 days ago Inside Information / Other news releases Innate Pharma to present interim results of IPH5201 in MATISSE Phase 2 study at AACR 2026. Study aims to enhance NSCLC treatment with anti-CD39 monoclonal antibody NSCLC Innate Pharma AACR 2026 MATISSE Phase 2 IPH5201
BRIEF published on 04/13/2026 at 07:05, 2 months 11 days ago Innate Pharma Updates Share and Voting Rights as of April 2026 Biotechnology Shares And Voting Rights Innate Pharma April 2026 Euronext Nasdaq
BRIEF published on 04/13/2026 at 07:05, 2 months 11 days ago Innate Pharma: Capital and Voting Rights Update Voting Rights Biotechnology Actions Immunotherapy Innate Pharma
PRESS RELEASE published on 04/13/2026 at 07:00, 2 months 11 days ago Inside Information / Other news releases Innate Pharma releases total shares and voting rights as of April 9, 2026, in compliance with French regulations. Learn about its innovative immunotherapies for cancer patients Voting Rights Shares French Regulations Innate Pharma Immunothérapies
PRESS RELEASE published on 04/13/2026 at 07:00, 2 months 11 days ago Inside Information / Other news releases Innate Pharma to hold its Annual General Meeting of shareholders on May 21, 2026 at 10:30 a.m. CEST in Marseille. Shareholders must register shares by May 14, 2026, 00:00 Paris time, to attend Annual General Meeting Shareholders Registration Innate Pharma Marseille
Published on 06/24/2026 at 03:15, 4 hours 59 minutes ago Noram Lithium Adopts Semi-Annual Financial Reporting
Published on 06/24/2026 at 00:00, 8 hours 14 minutes ago Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Published on 06/23/2026 at 23:45, 8 hours 29 minutes ago Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Published on 06/23/2026 at 23:20, 8 hours 54 minutes ago BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/23/2026 at 23:15, 8 hours 59 minutes ago EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects
Published on 06/24/2026 at 08:00, 13 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 06/24/2026 at 07:59, 14 minutes ago HEIDELBERG integrates the lifecycle business and global sales and service companies of the manroland sheetfed Group
Published on 06/24/2026 at 07:59, 14 minutes ago LEG Immobilien SE: Shareholders reinvest EUR 63.1 million through scrip dividend — 28.6% acceptance rate
Published on 06/24/2026 at 07:30, 43 minutes ago NAGA SECURES MICA AUTHORIZATION FOR CRYPTO-ASSET SERVICES ACROSS THE EU
Published on 06/23/2026 at 19:47, 12 hours 26 minutes ago GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 13 hours 3 minutes ago GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
Published on 06/23/2026 at 16:47, 15 hours 26 minutes ago Statement of transactions in own shares from June 15, 2026 to June 19, 2026
Published on 06/23/2026 at 15:44, 16 hours 29 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from June 15 to June 19 2026
Published on 06/23/2026 at 14:00, 18 hours 14 minutes ago Neoen awarded long-term contract for new 200 MW / 8-hour battery in Ontario, Canada
